Curoverse developed a genomic and biomedical computing platform designed to help researchers and clinicians manage, analyze, and securely share massive datasets—from sequencing to medical imaging—to accelerate drug development and precision medicine. Its open-source Arvados platform enables scalable processing of terabyte- to petabyte-scale biomedical data across cloud and on-premise environments.
Acquired by Veritas Genetics in August 2017.
